The world is absolutely teeming with viruses. The infectious agents are widely considered the most abundant biological entity on Earth. But a full understanding of viruses and the roles they play in our world is limited by our paltry knowledge of their incredible diversity.
Booster Therapeutics has launched with $15 million in seed financing and a mission to take on the current crop of targeted protein degraders.
Gritstone bio may have left no stone unturned when it came to searching for a financial rescue, but the vaccine biotech has decided that all roads now lead to bankruptcy.
The digital diabetes developer Glooko has collected $100 million and a new CEO to help boost the trajectory of its data management platform.
Finnish biotech Orion has spied potential in Aitia’s “digital twin” tech to develop new cancer drugs.
While Windtree Therapeutics has struggled to grow the financial roots needed to survive, a phase 2 win for the biotech’s lead asset will at least give the company encouragement to persevere.
An attempt by Merck & Co. to unlock the microsatellite stable (MSS) metastatic colorectal cancer market has ended in failure. The drugmaker found a fixed-dose combination of Keytruda and an anti-LAG-3 antibody failed to improve overall survival, extending the wait for a checkpoint inhibitor that moves the needle in the indication.
Health tech company PicnicHealth is launching a new program that lets researchers conduct clinical trials in cyberspace. Virtual Site is meant to help clinical trial sponsors conduct observational studies without the need for a physical location.
OncoC4 is taking AcroImmune—and its in-house clinical manufacturing capabilities—under its wing in an all-stock merger.
BioAge Labs is eyeing around $180 million in initial proceeds from an IPO and a private placement, funds the metabolic-focused biotech will use to push its lead obesity prospect through the clinic.
RFK Jr, noted vaccine sceptic, backs measles jab amid deadly US outbreak
Sad Case of The Youngest Person Ever Diagnosed With Alzheimer’s
Cell connects: Breaking barriers in stem cell communication through mRNA transfer
Fed-Batch Data Inadequate for Continuous Cultivation in Certain Systems
Pioneering work generates feline embryonic stem cells in boon for cats
Alzheimer’s Disease Could Be Influenced by HSV-1 Infections via Jumping Genes
RFK Jr. canceled flu vaccine meetings. What does that mean for fall shots?
What to know about the dangers of expired medications
Conservation focusing on birds of a feather may have mixed results
Cell connects: Breaking barriers in stem cell communication through mRNA transfer
